Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 556 AL 570

Natural products for the treatment of neurodegenerative diseases

Cui D, Chen Y, Ye B, Guo W, Wang D, He J.

Phytomedicine. 2023 Dec;121:155101. doi: 10.1016/j.phymed.2023.155101. Epub 2023 Sep 18.

GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disorders

Nicoletti F, Di Menna L, Iacovelli L, Orlando R, Zuena AR, Conn PJ, Dogra S, Joffe ME.

Neuropharmacology. 2023 Sep 1;235:109569. doi: 10.1016/j.neuropharm.2023.109569. Epub 2023 May 2.

Effect of arctigenin on neurological diseases: A review

Li M, Jiang H, Wang Y, Xu Z, Xu H, Chen Y, Zhu J, Lin Z, Zhang M.

J Ethnopharmacol. 2023 Oct 28;315:116642. doi: 10.1016/j.jep.2023.116642. Epub 2023 May 24.

Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease

Li L, Zhang J, Huang X, Du J, Tu Z, Wu H, Liu X, Yuan M.

Curr Pharm Des. 2023;29(2):95-115. doi: 10.2174/1381612829666221216114912.

Monoclonal antibodies for the management of central nervous system diseases: clinical success and future strategies

Singh Gautam A, Pandey SK, Lasure V, Dubey S, Singh RK.

Expert Opin Biol Ther. 2023 Jul-Dec;23(7):603-618. doi: 10.1080/14712598.2023.2227378. Epub 2023 Jun 27.

Nanocarrier-mediated curcumin delivery: An adjuvant strategy for CNS disease treatment

Godse S, Zhou L, Sakshi S, Singla B, Singh UP, Kumar S.

Exp Biol Med (Maywood). 2023 Nov;248(22):2151-2166. doi: 10.1177/15353702231211863. Epub 2023 Dec 6.

Neurological Applications of Celery (Apium graveolens): A Scoping Review

Tan TYC, Lim XY, Norahmad NA, Chanthira Kumar H, Teh BP, Lai NM, Syed Mohamed AF.

Molecules. 2023 Aug 2;28(15):5824. doi: 10.3390/molecules28155824.

Mitophagy: A promising therapeutic target for neuroprotection during ageing and age-related diseases

Mishra E, Thakur MK.

Br J Pharmacol. 2023 Jun;180(12):1542-1561. doi: 10.1111/bph.16062. Epub 2023 Mar 14.

Iron and Ferroptosis More than a Suspect: Beyond the Most Common Mechanisms of Neurodegeneration for New Therapeutic Approaches to Cognitive Decline and Dementia

Cerasuolo M, Di Meo I, Auriemma MC, Trojsi F, Maiorino MI, Cirillo M, Esposito F, Polito R, Colangelo AM, Paolisso G, Papa M, Rizzo MR.

Int J Mol Sci. 2023 Jun 1;24(11):9637. doi: 10.3390/ijms24119637.

Substance abuse and neurodegenerative diseases: focus on ferroptosis

Guo C, Chen L, Wang Y.

Arch Toxicol. 2023 Jun;97(6):1519-1528. doi: 10.1007/s00204-023-03505-4. Epub 2023 Apr 26.

Use of cannabidiol (CBD) for the treatment of cognitive impairment in psychiatric and neurological illness: A narrative review

Ortiz R, Rueda S, Di Ciano P.

Exp Clin Psychopharmacol. 2023 Oct;31(5):978-988. doi: 10.1037/pha0000659. Epub 2023 May 1.

Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review

Singh K, Bhushan B, Chanchal DK, Sharma SK, Rani K, Yadav MK, Porwal P, Kumar S, Sharma A, Virmani T, Kumar G, Noman AA.

Behav Neurol. 2023 Oct 12;2023:8825358. doi: 10.1155/2023/8825358. eCollection 2023.

Research progress of plant-derived natural alkaloids in central nervous system diseases

Zhang Q, Jiang Q, Sa K, Liang J, Sun D, Li H, Chen L.

Phytother Res. 2023 Nov;37(11):4885-4907. doi: 10.1002/ptr.7955. Epub 2023 Jul 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias